Matthew J Pfeffer
CIK 1192063 · CEO, CFO, Director · last filed 2019-06-05
Matthew J Pfeffer is a CEO, CFO, Director who has filed 47 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing, for EYESW, was dated Jun 5, 2019. Across all open-market trades the lifetime net is −$549.7K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $344.7K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
MNKD price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Vivani Medical, Inc. (EYESW) Delisted | Director | 118,301 | $0.22 | $26.0K | $0 | 3 | 2019-06-05 |
| MNKD | CEO, CFO, Director | 81,961 | $3.14 | $257.4K | -$547.3K | 34 | 2017-08-29 |
| EYES | Director | 2,880 | $30.33 | $87.4K | $0 | 2 | 2017-03-16 |
| DS HEALTHCARE GROUP, INC. (DSKX) Delisted | Director | 5,000 | — | — | $0 | 1 | 2014-02-18 |
| GENELABS TECHNOLOGIES INC /CA (GNLB) Delisted | Director | 0 | — | — | -$13.0K | 3 | 2009-01-07 |
| Diadexus, Inc. (AXC) Delisted | SENIOR VICE PRESIDENT AND CFO | 20,000 | — | — | $10.6K | 2 | 2007-12-04 |
Recent Filings
47 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-06-05 | Vivani Medical, Inc. (EYESW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-06-05 | Vivani Medical, Inc. (EYESW) Delisted | Grant (A) | +35,533 | $0 | EDGAR |
| 2017-08-29 | MNKD | Tax (F) | −303 | -$470 | EDGAR |
| 2017-08-23 | MNKD | Mixed | +1,647 | $2.0K | EDGAR |
| 2017-06-05 | Vivani Medical, Inc. (EYESW) Delisted | Grant (A) | +59,725 | $70.0K | EDGAR |
| 2017-03-16 | EYES | Grant (A) | +5,582 | $8.2K | EDGAR |
| 2017-01-04 | MNKD | Buy (P) | +4,540 | $2.5K | EDGAR |
| 2016-08-16 | MNKD | Buy (P) | +25,000 | $24.6K | EDGAR |
| 2016-06-03 | EYES | Grant (A) | +17,461 | $69.0K | EDGAR |
| 2016-02-29 | MNKD | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.